Tag: Diabetes: Misc.
Three Anti-VEGF Treatments Effective for Diabetic Retinopathy
Rates of worsening low in patients receiving aflibercept, bevacizumab, or ranibizumab
U-Shaped Correlation Between Body Mass Index, Mortality
The optimal BMI for lowest mortality is higher with worsening diabetes at each sex and age
RUNX1 May Play Role in Proliferative Diabetic Retinopathy
RUNX1 upregulated in CD31+ vascular endothelial cells from human PDR fibrovascular membranes
Diabetes Continues to Be a Significant Public Health Burden
But progress seen in cardiovascular complications, mortality among these patients
Metformin Use Does Not Increase Prostate Cancer Survival
Drug given in combination with docetaxel chemotherapy in patients with metastatic disease
DAPT Cessation Patterns Vary With Diabetes Status After PCI
Risk of major adverse cardiovascular events up for DAPT disruption, regardless of diabetes status
Teleretinal Diabetic Retinopathy Screening Ups Screening Rates
Implementation of TDRS program reduces median time to screening from 158 to 17 days
Virtual Service Boosts Glycemic Control in Hospitalized Adults
Decreases in hyperglycemia and hypoglycemia with vGMS for inpatients at three hospitals
Increased Use of Newer Meds for Diabetic Nephropathy in the U.S.
DDP-4 inhibitors used in 54 percent of visits in last quarter of 2014; ACE inhibitors, ARBs often used
Review: Several Classes of Drugs Treat Pain of Diabetic Neuropathy
Longer-term assessments of outcomes needed, researchers say
